Condition
Anticoagulants Causing Adverse Effects in Therapeutic Use
Total Trials
5
Recruiting
1
Active
1
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Completed4
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT04262492Recruiting
International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants
NCT04662515Completed
NOACs in Oral and Maxillofacial Surgery: Impact on Post-operative Complications
NCT03854149Completed
Apixaban in Adults With Congenital Heart Disease and Atrial Arrhythmias: the PROTECT-AR Study
NCT03264937Not ApplicableCompletedPrimary
Social-software iMproving wARfarin Therapy
NCT03828162CompletedPrimary
Atrial Fibrillation: Risk and Benefits of Anti-coagulation in the Elderly
Showing all 5 trials